These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11134761)

  • 1. Randomized trial of ondansetron, granisetron, and tropisetron in the prevention of acute nausea and vomiting.
    Lacerda JF; Martins C; Carmo JA; Lourenço MF; Araújo Pereira ME; Rodrigues A; Juncal C; Lacerda JM
    Transplant Proc; 2000 Dec; 32(8):2680-1. PubMed ID: 11134761
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiemetic efficacy of three serotonin antagonists during high-dose chemotherapy and autologous stem cell transplantation in malignant lymphoma.
    Slabý J; Trnený M; Procházka B; Klener P
    Neoplasma; 2000; 47(5):319-22. PubMed ID: 11130251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Granisetron, ondansetron, and tropisetron in the prophylaxis of acute nausea and vomiting induced by cisplatin for the treatment of head and neck cancer. A randomized controlled trial.
    Tremont-Lukats IW; Teixeira GM
    Cancer; 1996 Dec; 78(11):2450-3. PubMed ID: 8941020
    [No Abstract]   [Full Text] [Related]  

  • 4. Relative efficacy of ondansetron, granisetron, dolasetron and palonosetron in controlling acute nausea and vomiting associated with platinum-based chemotherapy.
    Hamadani M; Awab A; Chaudhary L; Tfayli A
    J Oncol Pharm Pract; 2006 Jun; 12(2):67-8. PubMed ID: 16984743
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of granisetron, ondansetron, and tropisetron in the prophylaxis of acute nausea and vomiting induced by cisplatin for the treatment of head and neck cancer: a randomized controlled trial.
    Mantovani G; Macciò A; Bianchi A; Curreli L; Ghiani M; Proto E; Santona MC
    Cancer; 1996 Mar; 77(5):941-8. PubMed ID: 8608488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Always more "setrons": how many do we need?
    Aapro MS
    Support Care Cancer; 1997 Jan; 5(1):1-2. PubMed ID: 9010981
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of granisetron, ondansetron and tropisetron for control of vomiting and nausea induced by cisplatin.
    Oge A; Alkiş N; Oge O; Kartum A
    J Chemother; 2000 Feb; 12(1):105-8. PubMed ID: 10768522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ondansetron and tropisetron in the control of nausea and vomiting in children receiving combined cancer chemotherapy.
    Stiakaki E; Savvas S; Lydaki E; Bolonaki I; Kouvidi E; Dimitriou H; Kambourakis A; Kalmanti M
    Pediatr Hematol Oncol; 1999; 16(2):101-8. PubMed ID: 10100270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ondansetron versus granisetron in the prevention of chemotherapy-induced nausea and vomiting.
    Fedele P; Spina M; Valentini M; Collini D; Lucia C; Manicone M; Tirelli U
    Cancer; 1995 Aug; 76(3):535-6. PubMed ID: 8625142
    [No Abstract]   [Full Text] [Related]  

  • 10. Granisetron, tropisetron, and ondansetron in the prevention of acute emesis induced by a combination of cisplatin-Adriamycin and by high-dose ifosfamide delivered in multiple-day continuous infusions.
    Forni C; Ferrari S; Loro L; Mazzei T; Beghelli C; Biolchini A; Simoni P; Tremosini M; Strazzari S; Puggioli C; Bacci G
    Support Care Cancer; 2000 Mar; 8(2):131-3. PubMed ID: 10739360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparable safety and antiemetic efficacy of a brief (30-second bolus) intravenous granisetron infusion and a standard (15-minute) intravenous ondansetron infusion in breast cancer patients receiving moderately emetogenic chemotherapy.
    Perez EA; Lembersky B; Kaywin P; Kalman L; Yocom K; Friedman C
    Cancer J Sci Am; 1998; 4(1):52-8. PubMed ID: 9467047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A randomized double-blind study of prevention of postoperative nausea and vomiting with ondansetron, tropisetron, or granisetron in patients undergoing general anesthesia].
    Quan X; Ye TH; Zhu B
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Feb; 29(1):107-10. PubMed ID: 17380679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress in preventing chemotherapy-induced nausea and vomiting.
    Markman M
    Cleve Clin J Med; 2002 Aug; 69(8):609-10, 612, 615-7. PubMed ID: 12184469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The clinical effect of Tropisetron in the prevention of nausea and vomiting induced by anti-cancer drugs].
    Wang J; Yang L; Cui C
    Zhonghua Zhong Liu Za Zhi; 2001 May; 23(3):251-3. PubMed ID: 11783100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients' self-reported functional status after granisetron or ondansetron therapy to prevent chemotherapy-induced nausea and vomiting at six cancer centers.
    Farley PA; Dempsey CL; Shillington AA; Kulis-Robitaille C; Colgan K; Bernstein G
    Am J Health Syst Pharm; 1997 Nov; 54(21):2478-82. PubMed ID: 9359954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of antiemetic efficacy of granisetron and ondansetron in Oriental patients: a randomized crossover study.
    Poon RT; Chow LW
    Br J Cancer; 1998 May; 77(10):1683-5. PubMed ID: 9635849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin receptor antagonists in prophylaxis of acute and delayed emesis induced by moderately emetogenic, single-day chemotherapy: a randomized study.
    Yalçin S; Tekuzman G; Baltali E; Ozişik Y; Barişta I
    Am J Clin Oncol; 1999 Feb; 22(1):94-6. PubMed ID: 10025391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised double blind crossover study comparing ondansetron, granisetron and tropisetron. A cost-benefit analysis.
    Barrajon E; de las Peñas R
    Support Care Cancer; 2000 Jul; 8(4):323-33. PubMed ID: 10923774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ondansetron versus granisetron in the prevention of chemotherapy induced nausea and vomiting in children with acute lymphoblastic leukemia.
    Siddique R; Hafiz MG; Rokeya B; Jamal CY; Islam A
    Mymensingh Med J; 2011 Oct; 20(4):680-8. PubMed ID: 22081189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-HT3 receptor antagonists in the prophylaxis of acute vomiting induced by moderately emetogenic chemotherapy--a randomised study.
    Jantunen IT; Muhonen TT; Kataja VV; Flander MK; Teerenhovi L
    Eur J Cancer; 1993; 29A(12):1669-72. PubMed ID: 8398291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.